{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:07:47Z","timestamp":1793066867891,"version":"4.5.0"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012465","name":"Dalian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.phymed.2019.152998","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T04:13:12Z","timestamp":1561608792000},"page":"152998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Interactions between artemisinin derivatives and P-glycoprotein"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3195-7978","authenticated-orcid":false,"given":"Yulin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2637-1681","authenticated-orcid":false,"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2019.152998_bib0001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02614215","article-title":"P-glycoprotein mediated resistance to 5\u2032-nor-anhydro-vinblastine (Navelbine)","volume":"13","author":"Adams","year":"1995","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.phymed.2019.152998_bib0002","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1055\/s-2007-993743","article-title":"Cytotoxicity and P-glycoprotein modulating effects of quinolones and indoloquinazolines from the Chinese herb Evodia rutaecarpa","volume":"73","author":"Adams","year":"2007","journal-title":"Planta Med."},{"key":"10.1016\/j.phymed.2019.152998_bib0003","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jat.1734","article-title":"In vitro evaluation of the cytotoxic and genotoxic effects of artemether, an antimalarial drug, in a gastric cancer cell line (PG100)","volume":"33","author":"Alcantara","year":"2013","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.phymed.2019.152998_bib0004","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding","volume":"323","author":"Aller","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.phymed.2019.152998_bib0005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1021\/js970372e","article-title":"P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels","volume":"87","author":"Anderle","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.phymed.2019.152998_bib0006","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4238\/2013.July.24.6","article-title":"Genotoxic evaluation of the antimalarial drugs artemisinin and artesunate in human HepG2 cells and effects on CASP3 and SOD1 gene expressions","volume":"12","author":"Aquino","year":"2013","journal-title":"Genet. Molecular Res."},{"key":"10.1016\/j.phymed.2019.152998_bib0007","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.bmcl.2009.02.013","article-title":"Semi-synthetic and synthetic 1,2,4-trioxaquines and 1,2,4-trioxolaquines: synthesis, preliminary SAR and comparison with acridine endoperoxide conjugates","volume":"19","author":"Araujo","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phymed.2019.152998_bib0008","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.taap.2004.06.017","article-title":"Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol","volume":"202","author":"Arora","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152998_bib0009","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0304-3835(02)00550-5","article-title":"Modulation of vinca-alkaloid induced P-glycoprotein expression by indole-3-carbinol","volume":"189","author":"Arora","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2019.152998_bib0010","article-title":"Inhibition of P-glycoprotein by two artemisinin derivatives","volume":"6","author":"Babette","year":"2012","journal-title":"Nat. Prod. Bioprospect."},{"key":"10.1016\/j.phymed.2019.152998_bib0011","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1208\/aapsj080101","article-title":"Current industrial practices of assessing permeability and P-glycoprotein interaction","volume":"8","author":"Balimane","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.phymed.2019.152998_bib0012","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejpb.2004.02.014","article-title":"Utility of 96 well Caco-2 cell system for increased throughput of P-gp screening in drug discovery","volume":"58","author":"Balimane","year":"2004","journal-title":"Eur. J.f Pharmaceutics Biopharmaceutics"},{"key":"10.1016\/j.phymed.2019.152998_bib0013","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1158\/1535-7163.MCT-11-0534","article-title":"Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM\/ATR damage response in cancer cells","volume":"10","author":"Berdelle","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phymed.2019.152998_bib0014","first-page":"1599","article-title":"Artesunate in the treatment of metastatic uveal melanoma-first experiences","volume":"14","author":"Berger","year":"2005","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phymed.2019.152998_bib0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.pt.2003.09.011","article-title":"Antimalarial chemotherapy: young guns or back to the future?","volume":"19","author":"Biagini","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.phymed.2019.152998_bib0016","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm.4381","article-title":"Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic","volume":"23","author":"Blasco","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2019.152998_bib0017","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/0006-2952(95)02112-4","article-title":"The effect of crown ethers, tetraalkylammonium salts, and polyoxyethylene amphiphiles on pirarubicin incorporation in K562 resistant cells","volume":"50","author":"Borrel","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152998_bib0018","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0020-7519(02)00195-9","article-title":"Antimalarial chemotherapeutic peroxides: artemisinin, yingzhaosu a and related compounds","volume":"32","author":"Borstnik","year":"2002","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.phymed.2019.152998_bib0019","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4269\/ajtmh.2007.77.193","article-title":"A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies","volume":"77","author":"Bosman","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.phymed.2019.152998_bib0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11259-007-9007-9","article-title":"Avermectin transepithelial transport in MDR1-and MRP-transfected canine kidney monolayers","volume":"32","author":"Brayden","year":"2008","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.phymed.2019.152998_bib0021","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s13659-014-0013-7","article-title":"Treatment of iron-loaded veterinary sarcoma by Artemisia annua","volume":"4","author":"Breuer","year":"2014","journal-title":"Nat. Prod. Bioprospect."},{"key":"10.1016\/j.phymed.2019.152998_bib0022","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bmcl.2013.11.032","article-title":"Synthesis of a novel series of artemisinin dimers with potent anticancer activity involving Sonogashira cross-coupling reaction","volume":"24","author":"Buragohain","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phymed.2019.152998_bib0023","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11095-018-2471-9","article-title":"Formulation of natural oil nano-emulsions for the topical delivery of clofazimine, artemisone and decoquinate","volume":"35","author":"Burger","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phymed.2019.152998_bib0024","doi-asserted-by":"crossref","DOI":"10.1124\/mol.104.009019","article-title":"Anti-malarial artemisinin drugs induce CYP and MDR1 expression by activation of xenosensors pregnane x receptor and constitutive androstane receptor","author":"Burk","year":"2005","journal-title":"Mole. Pharmacol"},{"key":"10.1016\/j.phymed.2019.152998_bib0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2125.2011.03961.x","article-title":"A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder","volume":"72","author":"Callegari","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152998_bib0026","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.106.012351","article-title":"Rapid identification of P-glycoprotein substrates and inhibitors","author":"Chang","year":"2006","journal-title":"Drug Metabolism Disposition."},{"key":"10.1016\/j.phymed.2019.152998_bib0027","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1039\/B816679J","article-title":"Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents","volume":"39","author":"Chaturvedi","year":"2010","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.phymed.2019.152998_bib0028","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1043-6618(03)00107-5","article-title":"Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro","volume":"48","author":"Chen","year":"2003","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2019.152998_bib0029","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.apsb.2016.01.006","article-title":"Mechanistic studies of the transport of peimine in the Caco-2 cell model","volume":"6","author":"Chen","year":"2016","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.phymed.2019.152998_bib0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1517\/17425255.4.5.581","article-title":"Prediction of oral drug absorption in humans\u2013from cultured cell lines and experimental animals","volume":"4","author":"Cheng","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.phymed.2019.152998_bib0031","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/BF02977349","article-title":"Inhibition of P-glycoprotein by natural products in human breast cancer cells","volume":"28","author":"Chung","year":"2005","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.phymed.2019.152998_bib0032","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jps.20780","article-title":"Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro\/in vivo case studies","volume":"96","author":"Constantinides","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.phymed.2019.152998_bib0033","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2007.08.021","article-title":"Molecular understanding and modern application of traditional medicines: triumphs and trials","volume":"130","author":"Corson","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2019.152998_bib0034","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.pnpbp.2007.01.028","article-title":"P-glycoprotein and cytochrome P450 3A4 involvement in risperidone transport using an in vitro Caco-2\/TC7 model and an in vivo model","volume":"31","author":"Cousein","year":"2007","journal-title":"Progress Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phymed.2019.152998_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/247597","article-title":"Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug","volume":"2012","author":"Crespo-Ortiz","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.phymed.2019.152998_bib0036","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1128\/AAC.00708-06","article-title":"Role of P-glycoprotein in absorption of novel antimalarial drugs","volume":"50","author":"Crowe","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2019.152998_bib0037","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1002\/jps.21744","article-title":"Comparison of bidirectional lamivudine and zidovudine transport using MDCK, MDCK-MDR1, and Caco-2 cell monolayers","volume":"98","author":"de Souza","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.phymed.2019.152998_bib0038","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1021\/jo962180u","article-title":"Analogs incorporating trans-4-hydroxy-l-proline that reverse multidrug resistance better than hapalosin","volume":"62","author":"Dinh","year":"1997","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.phymed.2019.152998_bib0039","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4269\/ajtmh.1994.51.785","article-title":"The pharmacokinetics of a single dose of artemisinin in healthy vietnamese subjects","volume":"51","author":"Duc","year":"1994","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.phymed.2019.152998_bib0040","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nrmicro2239","article-title":"Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria","volume":"7","author":"Eastman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.phymed.2019.152998_bib0041","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcp.2017.03.019","article-title":"Cancer combination therapies with artemisinin-type drugs","volume":"139","author":"Efferth","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152998_bib0043","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.phymed.2017.11.003","article-title":"Cancer combination therapy of the sesquiterpenoid artesunate and the selective EGFR-tyrosine kinase inhibitor erlotinib","volume":"37","author":"Efferth","year":"2017","journal-title":"Phytomed."},{"key":"10.1016\/j.phymed.2019.152998_bib0044","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","article-title":"From ancient herb to modern drug: artemisia annua and artemisinin for cancer therapy","volume":"46","author":"Efferth","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.phymed.2019.152998_bib0045","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.biotechadv.2018.01.001","article-title":"Beyond malaria: the inhibition of viruses by artemisinin-type compounds","volume":"36","author":"Efferth","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.phymed.2019.152998_bib0046","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/bcmd.2002.0492","article-title":"Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells","volume":"28","author":"Efferth","year":"2002","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.phymed.2019.152998_bib0047","first-page":"767","article-title":"The anti-malarial artesunate is also active against cancer","volume":"18","author":"Efferth","year":"2001","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.phymed.2019.152998_bib0048","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1371\/journal.pone.0000693","article-title":"Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells","volume":"2","author":"Efferth","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phymed.2019.152998_bib0049","first-page":"196","article-title":"Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs","volume":"46","author":"Efferth","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.phymed.2019.152998_bib0050","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/mol.64.2.382","article-title":"Molecular modes of action of artesunate in tumor cell lines","volume":"64","author":"Efferth","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152998_bib0051","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s00204-017-1938-5","article-title":"Multiple resistance to carcinogens and xenobiotics: P-glycoproteins as universal detoxifiers","volume":"91","author":"Efferth","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.phymed.2019.152998_bib0052","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1211\/0022357043969","article-title":"Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds\u2014implications for pharmacokinetics of selected substrates","volume":"56","author":"Ela","year":"2004","journal-title":"J. Pharmacy. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152998_bib0053","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/00498250701744625","article-title":"Ketoconazole and the modulation of multidrug resistance-mediated transport in Caco-2 and MDCKII-MDR1 drug transport models","volume":"38","author":"Fan","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.phymed.2019.152998_bib0054","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/clpt.2008.195","article-title":"Drug\u2013drug interactions mediated through P\u2010glycoprotein: clinical relevance and in vitro\u2013in vivo correlation using digoxin as a probe drug","volume":"85","author":"Fenner","year":"2009","journal-title":"Clin. Pharmacol. Therapeutics"},{"key":"10.1016\/j.phymed.2019.152998_bib0055","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.3390\/molecules15053135","article-title":"Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artemisinin against malaria and cancer","volume":"15","author":"Ferreira","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2019.152998_bib0056","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1017\/S1462399409001239","article-title":"Anticancer activities of artemisinin and its bioactive derivatives","volume":"11","author":"Firestone","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.phymed.2019.152998_bib0057","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0959-8049(01)00356-2","article-title":"The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7\/Adr cells","volume":"38","author":"Fu","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.phymed.2019.152998_bib0058","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4269\/ajtmh.2001.65.690","article-title":"Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy?","volume":"65","author":"Giao","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.phymed.2019.152998_bib0059","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1567201043480036","article-title":"The role of ABC transporters in drug resistance, metabolism and toxicity","volume":"1","author":"Glavinas","year":"2004","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.phymed.2019.152998_bib0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3923\/ijp.2005.85.92","article-title":"Modulation of MDR1 gene expression by a chronic treatment with verapamil in Caco-2 cells","volume":"1","author":"Granzotto","year":"2005","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152998_bib0061","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/bcpt.12084","article-title":"Role of P-glycoprotein in the uptake\/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model","volume":"113","author":"Gschwind","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.phymed.2019.152998_bib0062","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11655-009-0316-4","article-title":"Progress of research in antitumor mechanisms with Chinese medicine","volume":"15","author":"Han","year":"2009","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.phymed.2019.152998_bib0063","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s11095-008-9741-x","article-title":"Enhanced corneal absorption of erythromycin by modulating P-glycoprotein and MRP mediated efflux with corticosteroids","volume":"26","author":"Hariharan","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phymed.2019.152998_bib0064","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/anie.200503071","article-title":"Artemisone\u2013a highly active antimalarial drug of the artemisinin class","volume":"45","author":"Haynes","year":"2006","journal-title":"Angewandte Chemie"},{"key":"10.1016\/j.phymed.2019.152998_bib0065","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1128\/AAC.00893-13","article-title":"The unique and highly-selective anti-cytomegalovirus activities of artemisinin-derived dimer diphenyl phosphate stem from combination of dimer unit and a diphenyl phosphate moiety","volume":"57","author":"He","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.phymed.2019.152998_bib0066","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejpb.2012.07.020","article-title":"Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood\u2013brain barrier penetration models","volume":"82","author":"Hellinger","year":"2012","journal-title":"Eur. J. Pharmaceutics Biopharmaceutics"},{"key":"10.1016\/j.phymed.2019.152998_bib0067","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2174\/1567201815666180518125113","article-title":"Absorptive and secretory transport of selected artemisinin derivatives across Caco-2 cell monolayers","volume":"15","author":"Heyns","year":"2018","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.phymed.2019.152998_bib0068","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2019.152998_bib0069","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/1389200023337559","article-title":"Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug-drug interactions with P-glycoprotein","volume":"3","author":"Hochman","year":"2002","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.phymed.2019.152998_bib0070","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1021\/jm100404t","article-title":"Cytotoxicity of artesunic acid homo- and heterodimer molecules toward sensitive and multidrug-resistant CCRF-CEM leukemia cells","volume":"53","author":"Horwedel","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phymed.2019.152998_bib0071","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.trstmh.2005.09.020","article-title":"The history of qing hao in the Chinese materia medica","volume":"100","author":"Hsu","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.phymed.2019.152998_bib0072","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1016\/j.biomaterials.2009.09.008","article-title":"Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles","volume":"30","author":"Hu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.phymed.2019.152998_bib0073","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3346\/jkms.2006.21.2.253","article-title":"Prognostic significance of multidrug resistance gene 1 (MDR1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia","volume":"21","author":"Huh","year":"2006","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.phymed.2019.152998_bib0074","first-page":"4417","article-title":"First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers","volume":"31","author":"Jansen","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phymed.2019.152998_bib0075","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.vascn.2014.08.002","article-title":"Comparison of MDCK-MDR1 and Caco-2 cell based permeability assays for anti-malarial drug screening and drug investigations","volume":"70","author":"Jin","year":"2014","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.phymed.2019.152998_bib0076","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phymed.2019.152998_bib0077","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1021\/jm020119d","article-title":"Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer","volume":"46","author":"Jung","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phymed.2019.152998_bib0078","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/bjc.1988.291","article-title":"The multidrug resistance phenotype","volume":"58","author":"Kaye","year":"1988","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phymed.2019.152998_bib0079","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): an antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.phymed.2019.152998_bib0080","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ebiom.2014.11.010","article-title":"A randomised, double blind, placebo-controlled pilot study of oral artesunate therapy for colorectal cancer","volume":"2","author":"Krishna","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phymed.2019.152998_bib0081","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1476-5381.2010.00801.x","article-title":"Differences in the expression of endogenous efflux transporters in MDR1\u2010transfected versus wildtype cell lines affect P\u2010glycoprotein mediated drug transport","volume":"160","author":"Kuteykin\u2010Teplyakov","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152998_bib0082","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/S0006-3495(03)74630-X","article-title":"Assessment of multidrug resistance reversal using dielectrophoresis and flow cytometry","volume":"85","author":"Labeed","year":"2003","journal-title":"Biophys. J."},{"key":"10.1016\/j.phymed.2019.152998_bib0083","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","article-title":"Development of artemisinin compounds for cancer treatment","volume":"31","author":"Lai","year":"2013","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.phymed.2019.152998_bib0084","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jchromb.2015.05.001","article-title":"Determination and pharmacokinetic studies of artesunate and its metabolite in sheep plasma by liquid chromatography-tandem mass spectrometry","volume":"997","author":"Li","year":"2015","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.phymed.2019.152998_bib0085","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s12094-014-1169-7","article-title":"Compounds from Chinese herbal medicines as reversal agents for P-glycoprotein-mediated multidrug resistance in tumours","volume":"16","author":"Li","year":"2014","journal-title":"Clin. Translational Oncol."},{"key":"10.1016\/j.phymed.2019.152998_bib0086","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1158\/0008-5472.CAN-07-2970","article-title":"Artesunate derived from traditional Chinese medicine induces DNA damage and repair","volume":"68","author":"Li","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2019.152998_bib0087","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/aps.2012.104","article-title":"Qinghaosu (artemisinin): chemistry and pharmacology","volume":"33","author":"Li","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phymed.2019.152998_bib0088","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s13318-011-0026-0","article-title":"Assessment and modulation of phillyrin absorption by P-gp using Caco-2 cells and MDR1-MDCKII cells","volume":"36","author":"Li","year":"2011","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.phymed.2019.152998_bib0089","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.euroneuro.2007.06.003","article-title":"A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs","volume":"18","author":"Linnet","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phymed.2019.152998_bib0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0925-4439(97)00026-4","article-title":"Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity","volume":"1361","author":"Litman","year":"1997","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis Dis."},{"key":"10.1016\/j.phymed.2019.152998_bib0091","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.2174\/1381612821666150416102058","article-title":"Dendrimers in oral drug delivery application: current explorations, toxicity issues and strategies for improvement","volume":"21","author":"Liu","year":"2015","journal-title":"Curr. Pharmaceutical Des."},{"key":"10.1016\/j.phymed.2019.152998_bib0092","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1706","article-title":"Molecular mechanisms of drug resistance","volume":"205","author":"Longley","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.phymed.2019.152998_bib0093","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1021\/mp0500768","article-title":"Functional characterization of sodium-dependent multivitamin transporter in MDCK-MDR1 cells and its utilization as a target for drug delivery","volume":"3","author":"Luo","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phymed.2019.152998_bib0094","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/13880209.2016.1241810","article-title":"Chrysosplenetin inhibits artemisinin efflux in P-gp-over-expressing Caco-2 cells and reverses P-gp\/MDR1 mRNA up-regulated expression induced by artemisinin in mouse small intestine","volume":"55","author":"Ma","year":"2017","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.phymed.2019.152998_bib0095","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.exppara.2013.10.006","article-title":"Artemisone inhibits in vitro and in vivo propagation of babesia bovis and b. bigemina parasites","volume":"135","author":"Mazuz","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.phymed.2019.152998_bib0096","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1476-5829.2003.00009.x","article-title":"Dexamethasone treatment of a canine, but not human, tumour cell line increases chemoresistance independent of P\u2010glycoprotein and multidrug resistance\u2010related protein expression","volume":"1","author":"Mealey","year":"2003","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.phymed.2019.152998_bib0097","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.1073\/pnas.94.24.12908","article-title":"P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity","volume":"94","author":"Mechetner","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.phymed.2019.152998_bib0098","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0020-7519(02)00194-7","article-title":"Artemisinin: mechanisms of action, resistance and toxicity","volume":"32","author":"Meshnick","year":"2002","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.phymed.2019.152998_bib0099","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1128\/mr.60.2.301-315.1996","article-title":"Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy","volume":"60","author":"Meshnick","year":"1996","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.phymed.2019.152998_bib0100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bcp.2009.08.013","article-title":"Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines","volume":"79","author":"Michaelis","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152998_bib0101","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.phymed.2015.11.001","article-title":"Activity of Artemisia annua and artemisinin derivatives, in prostate carcinoma","volume":"22","author":"Michaelsen","year":"2015","journal-title":"Phytomed."},{"key":"10.1016\/j.phymed.2019.152998_bib0102","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2011.08.024","article-title":"Artemisinin: discovery from the Chinese herbal garden","volume":"146","author":"Miller","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2019.152998_bib0103","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.phymed.2018.10.014","article-title":"Effect of Artemisia annua and Artemisia afra tea infusions on schistosomiasis in a large clinical trial","volume":"51","author":"Munyangi","year":"2018","journal-title":"Phytomed."},{"key":"10.1016\/j.phymed.2019.152998_bib0104","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ddr.20345","article-title":"Next\u2010generation antimalarial drugs: hybrid molecules as a new strategy in drug design","volume":"71","author":"Muregi","year":"2010","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.phymed.2019.152998_bib0105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.phymed.2018.06.002","article-title":"The activity of Artemisia spp. and their constituents against trypanosomasis","volume":"47","author":"Na\u00df","year":"2018","journal-title":"Phytomed."},{"key":"10.1016\/j.phymed.2019.152998_bib0106","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1021\/bc060325q","article-title":"Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates","volume":"18","author":"Najlah","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.phymed.2019.152998_bib0107","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijpharm.2007.09.003","article-title":"Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation","volume":"354","author":"Nakase","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phymed.2019.152998_bib0108","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/hed.20524","article-title":"Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells","volume":"29","author":"Nam","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.phymed.2019.152998_bib0109","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1517\/13543776.2012.724063","article-title":"Artemisinin derivatives: a patent review (2006 - present)","volume":"22","author":"Njuguna","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.phymed.2019.152998_bib0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","article-title":"Artemisinin-based combination treatment of falciparum malaria","volume":"77","author":"Nosten","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.phymed.2019.152998_bib0111","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1517\/13543784.14.9.1117","article-title":"The therapeutic potential of semi-synthetic artemisinin and synthetic endoperoxide antimalarial agents","volume":"14","author":"O'Neill","year":"2005","journal-title":"Expert Opin. Investig Drugs"},{"key":"10.1016\/j.phymed.2019.152998_bib0112","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00280-008-0695-9","article-title":"Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo","volume":"62","author":"O'Reilly","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152998_bib0113","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4269\/ajtmh.2012.11-0817","article-title":"Potential P-glycoprotein-mediated drug-drug interactions of antimalarial agents in Caco-2 cells","volume":"87","author":"Oga","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.phymed.2019.152998_bib0114","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2008.08.031","article-title":"Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide","volume":"274","author":"Oh","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2019.152998_bib0115","series-title":"Treatment and Prevention of Malaria","first-page":"191","article-title":"Second-generation peroxides: the OZs and Artemisone","author":"Opsenica","year":"2011"},{"key":"10.1016\/j.phymed.2019.152998_bib0116","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/j.febslet.2006.02.020","article-title":"Mechanisms and strategies to overcome multiple drug resistance in cancer","volume":"580","author":"Ozben","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phymed.2019.152998_bib0117","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1056\/NEJM198705283162207","article-title":"Multiple-drug resistance in human cancer","volume":"316","author":"Pastan","year":"1987","journal-title":"New Eng. J. Med."},{"key":"10.1016\/j.phymed.2019.152998_bib0118","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/00498250310001630215","article-title":"Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats","volume":"34","author":"Perloff","year":"2004","journal-title":"Xenobiotica"},{"key":"10.1016\/j.phymed.2019.152998_bib0119","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13346-011-0051-1","article-title":"A novel nanoparticle formulation overcomes multiple types of membrane efflux pumps in human breast cancer cells","volume":"2","author":"Prasad","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.phymed.2019.152998_bib0120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.22270\/jddt.v3i3.506","article-title":"The impact of permeability enhancers on assessment for monolayer of colon adenocarcinoma cell line (CaCo-2) used in in vitropermeability assay","volume":"3","author":"Rastogi","year":"2013","journal-title":"J. Drug Delivery .Therapeutics"},{"key":"10.1016\/j.phymed.2019.152998_bib0121","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0928-0987(02)00055-6","article-title":"Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers","volume":"16","author":"Rege","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.phymed.2019.152998_bib0122","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejmech.2014.01.043","article-title":"Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparumand multidrug-resistant human leukemia cells","volume":"75","author":"Reiter","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phymed.2019.152998_bib0123","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.bmc.2015.07.048","article-title":"Highly potent artemisinin-derived dimers and trimers: synthesis and evaluation of their antimalarial, antileukemia and antiviral activities","volume":"23","author":"Reiter","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.phymed.2019.152998_bib0124","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmech.2015.04.053","article-title":"New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids","volume":"97","author":"Reiter","year":"2015","journal-title":"Eur. J .Med. Chem."},{"key":"10.1016\/j.phymed.2019.152998_bib0125","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1016\/j.bmc.2012.07.015","article-title":"New artesunic acid homodimers: potent reversal agents of multidrug resistance in leukemia cells","volume":"20","author":"Reiter","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.phymed.2019.152998_bib0126","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1248\/bpb.25.1555","article-title":"Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562\/adr and GLC4\/adr resistant cell lines","volume":"25","author":"Reungpatthanaphong","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phymed.2019.152998_bib0127","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1476-5381.2009.00117.x","article-title":"Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression","volume":"156","author":"Riganti","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152998_bib0128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/00498250500433545","article-title":"Plant polyphenols and multidrug resistance: effects of dietary flavonoids on drug transporters in Caco-2 and MDCKII-MDR1 cell transport models","volume":"36","author":"Rodriguez-Proteau","year":"2006","journal-title":"Xenobiotica"},{"key":"10.1016\/j.phymed.2019.152998_bib0129","first-page":"1819","article-title":"Safety and efficacy field study of artesunate for dogs with non-resectable tumours","volume":"33","author":"Rutteman","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phymed.2019.152998_bib0130","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.phrs.2016.02.017","article-title":"Antischistosomal activity of artemisinin derivatives in vivoand in patients","volume":"110","author":"Saeed","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2019.152998_bib0131","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00204-005-0041-5","article-title":"Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells","volume":"80","author":"Schrickx","year":"2006","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.phymed.2019.152998_bib0132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152677","article-title":"The interactions of P-glycoprotein with antimalarial drugs, including substrate affinity, inhibition and regulation","volume":"11","author":"Senarathna","year":"2016","journal-title":"PloS ONE"},{"key":"10.1016\/j.phymed.2019.152998_bib0133","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cbi.2010.02.002","article-title":"Factors determining sensitivity or resistance of tumor cell lines towards artesunate","volume":"185","author":"Sertel","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.phymed.2019.152998_bib0134","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s11655-011-0815-y","article-title":"Proliferation-inhibiting and apoptosis-inducing effects of ursolic acid and oleanolic acid on multi-drug resistance cancer cells in vitro","volume":"17","author":"Shan","year":"2011","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.phymed.2019.152998_bib0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1432-1033.1997.00130.x","article-title":"Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities","volume":"250","author":"Shapiro","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.phymed.2019.152998_bib0136","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj3330621","article-title":"Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation","volume":"333","author":"SHAROM","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.phymed.2019.152998_bib0137","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/138945011795378540","article-title":"Improving cancer chemotherapy with modulators of ABC drug transporters","volume":"12","author":"Shukla","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.phymed.2019.152998_bib0138","first-page":"2277","article-title":"Artemisinin induces apoptosis in human cancer cells","volume":"24","author":"Singh","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phymed.2019.152998_bib0139","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1016\/j.yexcr.2006.09.005","article-title":"P-gp localization in mitochondria and its functional characterization in multiple drug-resistant cell lines","volume":"312","author":"Solazzo","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.phymed.2019.152998_bib0140","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1582-4934.2010.01120.x","article-title":"Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties","volume":"15","author":"Soomro","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.phymed.2019.152998_bib0141","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1152\/physrev.1997.77.2.545","article-title":"Kinetics of the multidrug transporter (P-glycoprotein) and its reversal","volume":"77","author":"Stein","year":"1997","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phymed.2019.152998_bib0142","doi-asserted-by":"crossref","first-page":"e40720","DOI":"10.1371\/journal.pone.0040720","article-title":"Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-\u03baB in R-HepG2 cell line","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phymed.2019.152998_bib0143","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/138161206775201965","article-title":"An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy","volume":"12","author":"Takara","year":"2006","journal-title":"Curr. Pharm. Design"},{"key":"10.1016\/j.phymed.2019.152998_bib0144","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40249-015-0091-8","article-title":"Nobel prize for the artemisinin and ivermectin discoveries: a great boost towards elimination of the global infectious diseases of poverty","volume":"4","author":"Tambo","year":"2015","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.phymed.2019.152998_bib0145","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1023\/A:1016140429238","article-title":"Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?","volume":"19","author":"Tang","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phymed.2019.152998_bib0146","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.105.005421","article-title":"Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity","author":"Taub","year":"2005","journal-title":"Drug Metabolism and Disposition."},{"key":"10.1016\/j.phymed.2019.152998_bib0147","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00001813-199607000-00012","article-title":"Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay","volume":"7","author":"Tiberghien","year":"1996","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.phymed.2019.152998_bib0148","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.2042-7158.1990.tb07030.x","article-title":"The pharmacokinetics of artemisinin after oral, intramuscular and rectal administration to volunteers","volume":"42","author":"Titulaer","year":"1990","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152998_bib0149","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1473-3099(11)70194-3","article-title":"Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study","volume":"11","author":"Trape","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.phymed.2019.152998_bib0150","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1023\/A:1025096930604","article-title":"Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells","volume":"20","author":"Troutman","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phymed.2019.152998_bib0151","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2471","article-title":"The discovery of artemisinin (qinghaosu) and gifts from chinese medicine","volume":"17","author":"Tu","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2019.152998_bib0152","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.dmpk.2014.11.002","article-title":"Quantitative targeted absolute proteomics for 28 human transporters in plasma membrane of Caco-2 cell monolayer cultured for 2, 3, and 4 weeks","volume":"30","author":"Uchida","year":"2015","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.phymed.2019.152998_bib0153","first-page":"1","article-title":"Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy","volume":"9","author":"Ullah","year":"2008","journal-title":"Asian Pacific J. Cancer Prevention"},{"key":"10.1016\/j.phymed.2019.152998_bib0154","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.phymed.2017.08.004","article-title":"Modulation of P-glycoprotein by stemona alkaloids in human multidrug resistance leukemic cells and structural relationships","volume":"34","author":"Umsumarng","year":"2017","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2019.152998_bib0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0165-6147(99)01302-4","article-title":"Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication","volume":"20","author":"van Agtmael","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phymed.2019.152998_bib0156","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.4155\/fmc.11.149","article-title":"Drug-permeability and transporter assays in Caco-2 and MDCK cell lines","volume":"3","author":"Volpe","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.phymed.2019.152998_bib0157","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-017-4261-1","article-title":"Prospective open uncontrolled phase i study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33\/2)","volume":"164","author":"von Hagens","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.phymed.2019.152998_bib0158","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejmech.2015.06.002","article-title":"The interaction of 4-thiazolidinone derivatives containing indolin-2-one moiety with P-glycoprotein studied using K562 cell lines","volume":"101","author":"Wang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phymed.2019.152998_bib0159","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/j.bmcl.2013.05.057","article-title":"Synthesis of artemisinin dimers using the ugi reaction and their in vitro efficacy on breast cancer cells","volume":"23","author":"Wang","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phymed.2019.152998_bib0160","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.bbamem.2006.06.004","article-title":"A kinetic study of Rhodamine123 pumping by P-glycoprotein","volume":"1758","author":"Wang","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.phymed.2019.152998_bib0161","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nrd2972","article-title":"New medicines to improve control and contribute to the eradication of malaria","volume":"8","author":"Wells","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2019.152998_bib0162","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/np50096a007","article-title":"Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells","volume":"56","author":"Woerdenbag","year":"1993","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phymed.2019.152998_bib0163","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1734-1140(13)71021-1","article-title":"Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells","volume":"65","author":"Wu","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.phymed.2019.152998_bib0164","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.molstruc.2014.12.087","article-title":"Host\u2013guest inclusion system of artesunate with \u03b2-cyclodextrin and its derivatives: characterization and antitumor activity","volume":"1085","author":"Xie","year":"2015","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.phymed.2019.152998_bib0165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.canlet.2008.09.029","article-title":"Naturally-occurring shikonin analogues\u2013a class of necroptotic inducers that circumvent cancer drug resistance","volume":"274","author":"Xuan","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2019.152998_bib0166","first-page":"91","article-title":"Reversal of drug resistance in multidrug-resistant MCF-7\/ADR cells of breast cancer by artemisinin","volume":"40","author":"Yu","year":"2011","journal-title":"Acta Med Univ. Sci. Technol. Huazhong"},{"key":"10.1016\/j.phymed.2019.152998_bib0167","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1248\/cpb.56.831","article-title":"Design, synthesis and cytotoxicity of novel podophyllotoxin derivatives","volume":"56","author":"Yu","year":"2008","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.phymed.2019.152998_bib0168","article-title":"A promising microtubule inhibitor deoxypodophyllotoxin exhibits better efficacy to multi-drug resistant breast cancer than paclitaxel via avoiding efflux transport","volume":"117","author":"Zang","year":"2018","journal-title":"Drug Metabol. Disposition"},{"key":"10.1016\/j.phymed.2019.152998_bib0169","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.addr.2011.12.003","article-title":"The transport of antiepileptic drugs by P-glycoprotein","volume":"64","author":"Zhang","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phymed.2019.152998_bib0170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bmcl.2015.11.042","article-title":"Synthesis and biological evaluation of a novel artesunate-podophyllotoxin conjugate as anticancer agent","volume":"26","author":"Zhang","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phymed.2019.152998_bib0171","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1023\/A:1025044913766","article-title":"Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells","volume":"20","author":"Zhang","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phymed.2019.152998_bib0172","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12185-011-0798-7","article-title":"The effect of glucosylceramide synthase on P-glycoprotein function in K562\/AO2 leukemia drug-resistance cell line","volume":"93","author":"Zhang","year":"2011","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.phymed.2019.152998_bib0173","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00280-009-1229-9","article-title":"Syl611, a novel semisynthetic taxane derivative, reverses multidrug resistance by P-glycoprotein inhibition and facilitating inward transmembrane action","volume":"66","author":"Zhang","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152998_bib0174","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ejmech.2015.10.040","article-title":"Combating P-glycoprotein-mediated multidrug resistance with 10-O-phenyl dihydroartemisinin ethers in MCF-7 cells","volume":"108","author":"Zhong","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phymed.2019.152998_bib0175","first-page":"1953","article-title":"In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel","volume":"25","author":"Zhu","year":"2005","journal-title":"Anticancer Res."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711319301655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711319301655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:19:19Z","timestamp":1760552359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711319301655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":174,"alternative-id":["S0944711319301655"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2019.152998","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions between artemisinin derivatives and P-glycoprotein","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2019.152998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152998"}}